Biomarkers in frontotemporal dementia

Biomarkers in Medicine

Volumn 8, Issue 4, 2014, Pages 519-521

  Rohrer, Jonathan D ^a   Zetterberg, Henrik ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

C9orf72; frontotemporal dementia; FUS; progranulin; tau; TDP 43

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; GRN PROTEIN, HUMAN; PROTEIN TDP-43; RNA BINDING PROTEIN; SIGNAL PEPTIDE;

BRAIN ATROPHY; C9ORF72 GENE; DISEASE COURSE; DISEASE SEVERITY; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; GENETIC ASSOCIATION; GRN GENE; HUMAN; MAPT GENE; MARKER GENE; MOLECULAR PATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; BLOOD; CEREBROSPINAL FLUID; METABOLISM; PATHOLOGY;

BIOLOGICAL MARKERS; DNA-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RNA-BINDING PROTEIN FUS; TAU PROTEINS;

EID: 84899833216     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.14.30     Document Type: Review

References (28)

1. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J. Neurol. Neurosurg. Psychiatry 82(5), 476-486 (2011).
2. Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr. Opin. Neurol. 24(6), 542-549 (2011).
3. Rohrer JD, Rosen H. Neuroimaging of frontotemporal dementia. Int. Rev. Psychiatry 25(2), 221-229 (2013).
4. Rohrer JD, Ridgway GR, Modat M et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 53(3), 1070-1076 (2010).
5. Rohrer JD, Lashley T, Schott JM et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134(9), 2565-2581 (2011).
6. Whitwell JL, Weigand SD, Boeve BF et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 135(Pt 3), 794-806 (2012).
7. McMillan CT, Irwin DJ, Avants BB et al. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J. Neurol. Neurosurg. Psychiatry 84(9), 949-955 (2013).
8. Knopman DS, Kramer JH, Boeve BF et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131(Pt 11), 2957-2968 (2008).
9. Gordon E, Rohrer JD, Kim LG et al. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology 74(8), 666-673 (2010).
10. Rohrer JD, Clarkson MJ, Kittus R et al. Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. J. Alzheimers Dis. 30(2), 407-411 (2012).
11. Ghidoni R, Stoppani E, Rossi G et al. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. Neurodegener. Dis. 9(3), 121-127 (2012).
12. Bian H, Van Swieten JC, Leight S et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70(19 Pt 2), 1827-1835 (2008).
13. Rosso SM, van Herpen E, Pijnenburg YA et al. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations. Arch Neurol. 60(9), 1209-1213 (2003).
14. Foulds PG, Davidson Y, Mishra M. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 118(5), 647-658 (2009).
15. Suárez-Calvet M, Dols-Icardo O, Lladó A. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J. Neurol. Neurosurg. Psychiatry doi:10.1136/jnnp-2013-305972 (2013) (Epub ahead of print).
16. Landqvist Waldö M, Frizell Santillo A, Passant U et al. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia. BMC Neurol. 13, 54 (2013).
17. Hu WT, Chen-Plotkin A, Grossman M et al. Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology 75(23), 2079-2086 (2010).
18. Hu WT, Watts K, Grossman M et al. Reduced CSF p-tau181 to tau ratio is a biomarker for FTLD-TDP. Neurology 81(22), 1945-1952 (2013).
19. Scherling CS, Hall T, Berisha F. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol. doi:10.1002/ ana.24052 (2013) (Epub ahead of print).
20. Martens LH, Zhang J, Barmada SJ et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Invest. 122(11), 3955-3959 (2012).
21. Lant SB, Robinson AC, Thompson JC. Patterns of microglial cell activation in frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. doi:10.1111/ nan.12092 (2013) (Epub ahead of print).
22. Bossù P, Salani F, Alberici A et al. Loss of function mutations in the progranulin gene are related to proinflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J. Neuroinflammation 8, 65 (2011).
23. Miller ZA, Rankin KP, Graff-Radford NR. TDP-43 frontotemporal lobar degeneration and autoimmune disease. J. Neurol. Neurosurg. Psychiatry 84(9), 956-962 (2013).
24. Chien DT, Bahri S, Szardenings AK et al. Early clinical PET imaging results with the novel PHF-tauradioligand [F-18]-T807. J. Alzheimers Dis. 34(2), 457-468 (2013).
25. Bateman RJ, Xiong C, Benzinger TL et al.; Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367(9), 795-804 (2012).
26. Rohrer JD, Warren JD, Fox NC, Rossor MN. Presymptomatic studies in genetic frontotemporal dementia. Rev. Neurol. (Paris) 169(10), 820-824 (2013).
27. Borroni B, Alberici A, Cercignani M et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol. Aging 33(10), 2506-2520 (2012).
28. Dopper EG, Rombouts SA, Jiskoot LC et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology 80(9), 814-823 (2013).